Fineline Cube

Follow:
14735 Articles
CompanyDrug

Innovent Biologics Withdraws Parsaclisib Filing in China, Halts Development

CompanyDeals

Jiangsu Hengrui Licenses Pyrotinib to Dr. Reddy’s for Indian Market

Policy / Regulatory

Beijing Joins Jiangxi’s Interferon Volume-Based Procurement Initiative

CompanyDeals

Sanofi Enters Collaboration with Teva for IBD Drug TEV’574 Development

CompanyDrug

AstraZeneca Reports Positive Phase III Results for Forxiga in Children with Type 2 Diabetes

Company

Sandoz Becomes Independent After Spin-Off from Novartis

CompanyDeals

Eli Lilly Acquires Point Biopharma to Enhance Oncology Portfolio

CompanyDrug

Sanofi’s Nexviazyme Approved in China as Enzyme Replacement Therapy for Pompe Disease

Policy / Regulatory

NMPA and NHC Tighten Regulations on Etomidate and Modafinil

CompanyDeals

Hangzhou HealSun Biopharm Secures RMB 200 Million in Series B+ Financing

Company

Viatris to Divest Women’s Health and API Businesses, Offloading 12 Factories and 6,000 Employees

CompanyDeals

Janssen and Sanofi Partner for Development of First-in-Class E. coli Vaccine